Symbol:
Slc44a2
Name:
solute carrier family 44 member 2
RGD ID:
1309680
Description:
Predicted to enable choline transmembrane transporter activity and ethanolamine transmembrane transporter activity. Predicted to be involved in several processes, including choline transport; ethanolamine transport; and positive regulation of canonical NF-kappaB signal transduction. Predicted to be located in mitochondrial outer membrane and plasma membrane. Predicted to be active in membrane. Orthologous to human SLC44A2 (solute carrier family 44 member 2 (CTL2 blood group)); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
choline transporter-like protein 2; LOC363024; MGC187957; RGD1309680; similar to RIKEN cDNA 1110028E10; solute carrier family 44 (choline transporter), member 2; solute carrier family 44, member 2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SLC44A2 (solute carrier family 44 member 2 (CTL2 blood group))
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Slc44a2 (solute carrier family 44, member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Slc44a2 (solute carrier family 44 member 2 (CTL2 blood group))
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SLC44A2 (solute carrier family 44 member 2 (CTL2 blood group))
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SLC44A2 (solute carrier family 44 member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Slc44a2 (solute carrier family 44 member 2 (CTL2 blood group))
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SLC44A2 (solute carrier family 44 member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
SLC44A2 (solute carrier family 44 member 2 (CTL2 blood group))
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Slc44a2 (solute carrier family 44 member 2 (CTL2 blood group))
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
SLC44A2 (solute carrier family 44 member 2 (CTL2 blood group))
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Slc44a2 (solute carrier family 44, member 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
zgc:63569
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Danio rerio (zebrafish):
slc44a2 (solute carrier family 44 member 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
chtl-1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Ctl2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
slc44a2
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 28,147,023 - 28,181,496 (+) NCBI GRCr8 mRatBN7.2 8 19,870,867 - 19,905,345 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 19,870,888 - 19,905,342 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 23,908,136 - 23,925,261 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 22,205,976 - 22,223,103 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 20,117,890 - 20,135,016 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 22,351,277 - 22,385,869 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 22,368,745 - 22,385,864 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 22,405,625 - 22,439,986 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 20,433,914 - 20,451,580 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 20,415,930 - 20,450,341 (+) NCBI Celera 8 21,279,682 - 21,296,806 (+) NCBI Celera Cytogenetic Map 8 q13 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Slc44a2 Rat 1,2-dimethylhydrazine increases expression ISO RGD:1615873 6480464 1,2-Dimethylhydrazine results in increased expression of SLC44A2 mRNA CTD PMID:22206623 Slc44a2 Rat 1,2-dimethylhydrazine multiple interactions ISO RGD:1615873 6480464 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of SLC44A2 mRNA] CTD PMID:22206623 Slc44a2 Rat 17beta-estradiol multiple interactions ISO RGD:1601745 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SLC44A2 mRNA CTD PMID:20660070 Slc44a2 Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1615873 6480464 2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLC44A2 mRNA CTD PMID:31388691 Slc44a2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1615873 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLC44A2 promoter] CTD PMID:19654925 Slc44a2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC44A2 mRNA CTD PMID:33387578 Slc44a2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC44A2 mRNA CTD PMID:34747641 Slc44a2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615873 6480464 Tetrachlorodibenzodioxin affects the expression of SLC44A2 mRNA CTD PMID:21570461 Slc44a2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1615873 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC44A2 mRNA CTD PMID:19465110|PMID:19770486 Slc44a2 Rat 2,4,6-tribromophenol increases expression ISO RGD:1601745 6480464 2,4,6-tribromophenol results in increased expression of SLC44A2 mRNA CTD PMID:31675489 Slc44a2 Rat 2,6-dimethoxyphenol multiple interactions ISO RGD:1601745 6480464 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the more ... CTD PMID:38598786 Slc44a2 Rat 2-bromohexadecanoic acid multiple interactions ISO RGD:1601745 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... CTD PMID:38195004 Slc44a2 Rat 2-hydroxypropanoic acid decreases expression ISO RGD:1601745 6480464 Lactic Acid results in decreased expression of SLC44A2 mRNA CTD PMID:30851411 Slc44a2 Rat 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1601745 6480464 tetrabromobisphenol A results in increased expression of SLC44A2 protein CTD PMID:31675489 Slc44a2 Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1601745 6480464 bisphenol S results in increased expression of SLC44A2 mRNA CTD PMID:25912373 Slc44a2 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Slc44a2 Rat 4,4'-sulfonyldiphenol affects methylation ISO RGD:1615873 6480464 bisphenol S affects the methylation of SLC44A2 gene CTD PMID:31683443 Slc44a2 Rat 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1615873 6480464 bisphenol S results in decreased methylation of SLC44A2 exon CTD PMID:33297965 Slc44a2 Rat 4-hydroxyphenyl retinamide decreases expression ISO RGD:1615873 6480464 Fenretinide results in decreased expression of SLC44A2 mRNA CTD PMID:28973697 Slc44a2 Rat 4-phenylbutyric acid increases expression ISO RGD:1601745 6480464 4-phenylbutyric acid results in increased expression of CTL2 mRNA CTD PMID:14583596 Slc44a2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC44A2 mRNA CTD PMID:24780913 Slc44a2 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC44A2 mRNA CTD PMID:31881176 Slc44a2 Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC44A2 mRNA CTD PMID:28959563 Slc44a2 Rat allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Slc44a2 Rat aristolochic acid A increases expression ISO RGD:1601745 6480464 aristolochic acid I results in increased expression of SLC44A2 mRNA CTD PMID:33212167 Slc44a2 Rat arsane affects expression ISO RGD:1601745 6480464 Arsenic affects the expression of SLC44A2 mRNA CTD PMID:18414638 Slc44a2 Rat arsane affects methylation ISO RGD:1601745 6480464 Arsenic affects the methylation of SLC44A2 gene CTD PMID:25304211 Slc44a2 Rat arsenic atom affects expression ISO RGD:1601745 6480464 Arsenic affects the expression of SLC44A2 mRNA CTD PMID:18414638 Slc44a2 Rat arsenic atom affects methylation ISO RGD:1601745 6480464 Arsenic affects the methylation of SLC44A2 gene CTD PMID:25304211 Slc44a2 Rat benzene-1,2,4-triol decreases expression ISO RGD:1601745 6480464 hydroxyhydroquinone results in decreased expression of SLC44A2 mRNA CTD PMID:39245080 Slc44a2 Rat benzo[a]pyrene decreases expression ISO RGD:1615873 6480464 Benzo(a)pyrene results in decreased expression of SLC44A2 mRNA CTD PMID:19770486 Slc44a2 Rat benzo[a]pyrene affects methylation ISO RGD:1601745 6480464 Benzo(a)pyrene affects the methylation of SLC44A2 promoter CTD PMID:27901495 Slc44a2 Rat beta-lapachone increases expression ISO RGD:1601745 6480464 beta-lapachone results in increased expression of SLC44A2 mRNA CTD PMID:38218311 Slc44a2 Rat bis(2-chloroethyl) sulfide increases expression ISO RGD:1601745 6480464 Mustard Gas results in increased expression of SLC44A2 mRNA CTD PMID:25102026 Slc44a2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC44A2 mRNA CTD PMID:25181051 Slc44a2 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Slc44a2 Rat bisphenol A decreases expression ISO RGD:1601745 6480464 bisphenol A results in decreased expression of SLC44A2 protein CTD PMID:31675489 Slc44a2 Rat bisphenol A increases expression ISO RGD:1601745 6480464 bisphenol A results in increased expression of SLC44A2 mRNA CTD PMID:29275510 Slc44a2 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC44A2 gene CTD PMID:28505145 Slc44a2 Rat bisphenol AF increases expression ISO RGD:1601745 6480464 bisphenol AF results in increased expression of SLC44A2 mRNA CTD PMID:25912373 Slc44a2 Rat bisphenol F decreases expression ISO RGD:1615873 6480464 bisphenol F results in decreased expression of SLC44A2 mRNA CTD PMID:38685157 Slc44a2 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Slc44a2 Rat C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of SLC44A2 mRNA CTD PMID:19167457 Slc44a2 Rat cadmium atom multiple interactions ISO RGD:1601745 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... CTD PMID:38195004 Slc44a2 Rat cadmium dichloride multiple interactions ISO RGD:1601745 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... CTD PMID:38195004 Slc44a2 Rat cantharidin decreases expression ISO RGD:1615873 6480464 Cantharidin results in decreased expression of SLC44A2 mRNA CTD PMID:36907384 Slc44a2 Rat cisplatin multiple interactions ISO RGD:1601745 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC44A2 mRNA CTD PMID:27392435 Slc44a2 Rat copper atom multiple interactions ISO RGD:1601745 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC44A2 mRNA CTD PMID:24690739 Slc44a2 Rat copper(0) multiple interactions ISO RGD:1601745 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC44A2 mRNA CTD PMID:24690739 Slc44a2 Rat copper(II) chloride decreases expression ISO RGD:1601745 6480464 cupric chloride results in decreased expression of SLC44A2 mRNA CTD PMID:38568856 Slc44a2 Rat copper(II) sulfate increases expression ISO RGD:1601745 6480464 Copper Sulfate results in increased expression of SLC44A2 mRNA CTD PMID:20599845 Slc44a2 Rat copper(II) sulfate decreases expression ISO RGD:1601745 6480464 Copper Sulfate results in decreased expression of SLC44A2 mRNA CTD PMID:20599845 Slc44a2 Rat cyclosporin A decreases expression ISO RGD:1601745 6480464 Cyclosporine results in decreased expression of SLC44A2 mRNA CTD PMID:24907557 Slc44a2 Rat cyclosporin A increases expression ISO RGD:1601745 6480464 Cyclosporine results in increased expression of SLC44A2 mRNA CTD PMID:25562108 Slc44a2 Rat cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Slc44a2 Rat cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Slc44a2 Rat decabromodiphenyl ether increases expression ISO RGD:1601745 6480464 decabromobiphenyl ether results in increased expression of SLC44A2 protein CTD PMID:31675489 Slc44a2 Rat disulfiram multiple interactions ISO RGD:1601745 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC44A2 mRNA CTD PMID:24690739 Slc44a2 Rat doxorubicin affects expression ISO RGD:1601745 6480464 Doxorubicin affects the expression of SLC44A2 mRNA CTD PMID:29803840 Slc44a2 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC44A2 mRNA CTD PMID:29391264 Slc44a2 Rat ethanol increases expression ISO RGD:1601745 6480464 Ethanol results in increased expression of SLC44A2 mRNA CTD PMID:28986285 Slc44a2 Rat ethanol affects splicing ISO RGD:1615873 6480464 Ethanol affects the splicing of SLC44A2 mRNA CTD PMID:30319688 Slc44a2 Rat ethanol increases expression ISO RGD:1615873 6480464 Ethanol results in increased expression of SLC44A2 mRNA CTD PMID:30319688 Slc44a2 Rat fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Slc44a2 Rat folic acid multiple interactions ISO RGD:1615873 6480464 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of SLC44A2 mRNA] CTD PMID:22206623 Slc44a2 Rat fonofos increases methylation ISO RGD:1601745 6480464 Fonofos results in increased methylation of SLC44A2 promoter CTD PMID:22847954 Slc44a2 Rat furfural multiple interactions ISO RGD:1601745 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of more ... CTD PMID:38598786 Slc44a2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC44A2 mRNA CTD PMID:22061828 Slc44a2 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC44A2 mRNA CTD PMID:33387578 Slc44a2 Rat hydrogen cyanide decreases expression ISO RGD:1615873 6480464 Hydrogen Cyanide results in decreased expression of SLC44A2 mRNA CTD PMID:33914522 Slc44a2 Rat leflunomide increases expression ISO RGD:1601745 6480464 leflunomide results in increased expression of SLC44A2 mRNA CTD PMID:28988120 Slc44a2 Rat lipopolysaccharide multiple interactions ISO RGD:1601745 6480464 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC44A2 mRNA CTD PMID:35811015 Slc44a2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SLC44A2 gene CTD PMID:35440735 Slc44a2 Rat N-Nitrosopyrrolidine increases expression ISO RGD:1601745 6480464 N-Nitrosopyrrolidine results in increased expression of SLC44A2 mRNA CTD PMID:32234424 Slc44a2 Rat O-methyleugenol increases expression ISO RGD:1601745 6480464 methyleugenol results in increased expression of SLC44A2 mRNA CTD PMID:32234424 Slc44a2 Rat ozone multiple interactions ISO RGD:1615873 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC44A2 more ... CTD PMID:34911549 Slc44a2 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC44A2 mRNA CTD PMID:33387578 Slc44a2 Rat parathion increases methylation ISO RGD:1601745 6480464 Parathion results in increased methylation of SLC44A2 promoter CTD PMID:22847954 Slc44a2 Rat potassium cyanide decreases expression ISO RGD:1615873 6480464 Potassium Cyanide results in decreased expression of SLC44A2 mRNA CTD PMID:33914522 Slc44a2 Rat progesterone multiple interactions ISO RGD:1601745 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SLC44A2 mRNA CTD PMID:20660070 Slc44a2 Rat pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of SLC44A2 protein CTD PMID:34896426 Slc44a2 Rat rac-lactic acid decreases expression ISO RGD:1601745 6480464 Lactic Acid results in decreased expression of SLC44A2 mRNA CTD PMID:30851411 Slc44a2 Rat resorcinol decreases expression ISO RGD:1601745 6480464 resorcinol results in decreased expression of SLC44A2 mRNA CTD PMID:22623647 Slc44a2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1601745 6480464 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC44A2 mRNA CTD PMID:35811015 Slc44a2 Rat SB 431542 multiple interactions ISO RGD:1601745 6480464 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SLC44A2 more ... CTD PMID:37664457 Slc44a2 Rat silicon dioxide decreases expression ISO RGD:1601745 6480464 Silicon Dioxide analog results in decreased expression of SLC44A2 mRNA CTD PMID:25895662 Slc44a2 Rat sodium arsenite decreases expression ISO RGD:1601745 6480464 sodium arsenite results in decreased expression of SLC44A2 mRNA CTD PMID:38568856 Slc44a2 Rat sodium chloride multiple interactions ISO RGD:1601745 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of more ... CTD PMID:38598786 Slc44a2 Rat Soman increases expression EXP 6480464 Soman results in increased expression of SLC44A2 mRNA CTD PMID:19281266 Slc44a2 Rat tamoxifen affects expression ISO RGD:1615873 6480464 Tamoxifen affects the expression of SLC44A2 mRNA CTD PMID:20937368 Slc44a2 Rat terbufos increases methylation ISO RGD:1601745 6480464 terbufos results in increased methylation of SLC44A2 promoter CTD PMID:22847954 Slc44a2 Rat tetrachloromethane affects expression ISO RGD:1615873 6480464 Carbon Tetrachloride affects the expression of SLC44A2 mRNA CTD PMID:17484886 Slc44a2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC44A2 mRNA CTD PMID:34492290 Slc44a2 Rat triphenyl phosphate affects expression ISO RGD:1601745 6480464 triphenyl phosphate affects the expression of SLC44A2 mRNA CTD PMID:37042841 Slc44a2 Rat triptonide affects expression ISO RGD:1615873 6480464 triptonide affects the expression of SLC44A2 mRNA CTD PMID:33045310 Slc44a2 Rat urethane increases expression ISO RGD:1601745 6480464 Urethane results in increased expression of SLC44A2 mRNA CTD PMID:28818685 Slc44a2 Rat valproic acid affects expression ISO RGD:1615873 6480464 Valproic Acid affects the expression of SLC44A2 mRNA CTD PMID:17292431 Slc44a2 Rat valproic acid increases expression ISO RGD:1601745 6480464 Valproic Acid results in increased expression of SLC44A2 mRNA CTD PMID:23179753|PMID:28001369|PMID:29154799 Slc44a2 Rat valproic acid increases expression ISO RGD:1615873 6480464 Valproic Acid results in increased expression of SLC44A2 mRNA CTD PMID:21427059 Slc44a2 Rat vancomycin decreases expression ISO RGD:1615873 6480464 Vancomycin results in decreased expression of SLC44A2 mRNA CTD PMID:18930951 Slc44a2 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SLC44A2 mRNA CTD PMID:19015723 Slc44a2 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC44A2 mRNA CTD PMID:23034163 Slc44a2 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC44A2 mRNA CTD PMID:23034163 Slc44a2 Rat zoledronic acid decreases expression ISO RGD:1601745 6480464 zoledronic acid results in decreased expression of SLC44A2 mRNA CTD PMID:24714768
1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-tribromophenol (ISO) 2,6-dimethoxyphenol (ISO) 2-bromohexadecanoic acid (ISO) 2-hydroxypropanoic acid (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 4,4'-sulfonyldiphenol (EXP,ISO) 4-hydroxyphenyl retinamide (ISO) 4-phenylbutyric acid (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) acrylamide (EXP) allethrin (EXP) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) benzene-1,2,4-triol (ISO) benzo[a]pyrene (ISO) beta-lapachone (ISO) bis(2-chloroethyl) sulfide (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) bisphenol F (EXP,ISO) C60 fullerene (EXP) cadmium atom (ISO) cadmium dichloride (ISO) cantharidin (ISO) cisplatin (ISO) copper atom (ISO) copper(0) (ISO) copper(II) chloride (ISO) copper(II) sulfate (ISO) cyclosporin A (ISO) cyhalothrin (EXP) cypermethrin (EXP) decabromodiphenyl ether (ISO) disulfiram (ISO) doxorubicin (ISO) endosulfan (EXP) ethanol (ISO) fenvalerate (EXP) folic acid (ISO) fonofos (ISO) furfural (ISO) gentamycin (EXP) hydrogen cyanide (ISO) leflunomide (ISO) lipopolysaccharide (ISO) methoxychlor (EXP) N-Nitrosopyrrolidine (ISO) O-methyleugenol (ISO) ozone (ISO) paracetamol (EXP) parathion (ISO) potassium cyanide (ISO) progesterone (ISO) pyrethrins (EXP) rac-lactic acid (ISO) resorcinol (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) silicon dioxide (ISO) sodium arsenite (ISO) sodium chloride (ISO) Soman (EXP) tamoxifen (ISO) terbufos (ISO) tetrachloromethane (ISO) thioacetamide (EXP) triphenyl phosphate (ISO) triptonide (ISO) urethane (ISO) valproic acid (ISO) vancomycin (ISO) vinclozolin (EXP) zoledronic acid (ISO)
Slc44a2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 28,147,023 - 28,181,496 (+) NCBI GRCr8 mRatBN7.2 8 19,870,867 - 19,905,345 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 19,870,888 - 19,905,342 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 23,908,136 - 23,925,261 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 22,205,976 - 22,223,103 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 20,117,890 - 20,135,016 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 22,351,277 - 22,385,869 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 22,368,745 - 22,385,864 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 22,405,625 - 22,439,986 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 20,433,914 - 20,451,580 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 20,415,930 - 20,450,341 (+) NCBI Celera 8 21,279,682 - 21,296,806 (+) NCBI Celera Cytogenetic Map 8 q13 NCBI
SLC44A2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 19 10,602,455 - 10,644,557 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 19 10,602,457 - 10,644,557 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 19 10,713,131 - 10,755,233 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 19 10,597,229 - 10,616,232 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 19 10,607,867 - 10,649,985 (+) NCBI Celera Cytogenetic Map 19 p13.2 NCBI HuRef 19 10,290,915 - 10,332,787 (+) NCBI HuRef CHM1_1 19 10,714,363 - 10,756,490 (+) NCBI CHM1_1 T2T-CHM13v2.0 19 10,728,929 - 10,771,033 (+) NCBI T2T-CHM13v2.0
Slc44a2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 21,232,015 - 21,266,324 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 21,231,994 - 21,266,324 (+) Ensembl GRCm39 Ensembl GRCm38 9 21,320,719 - 21,355,028 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 21,320,698 - 21,355,028 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 21,142,296 - 21,159,472 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 21,088,254 - 21,105,430 (+) NCBI MGSCv36 mm8 Celera 9 18,606,541 - 18,623,717 (+) NCBI Celera Cytogenetic Map 9 A3 NCBI cM Map 9 7.77 NCBI
Slc44a2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955495 1,791,508 - 1,807,216 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955495 1,780,766 - 1,804,944 (+) NCBI ChiLan1.0 ChiLan1.0
SLC44A2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 20 15,520,898 - 15,563,477 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 19 14,519,485 - 14,562,069 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 19 10,154,320 - 10,196,898 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 19 10,815,825 - 10,857,693 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 19 10,815,820 - 10,857,693 (+) Ensembl panpan1.1 panPan2
SLC44A2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 20 50,557,816 - 50,571,137 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 20 50,551,249 - 50,607,200 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 20 50,430,322 - 50,459,391 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 20 51,076,057 - 51,093,668 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 20 51,082,994 - 51,130,343 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 20 50,292,534 - 50,316,940 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 20 50,715,881 - 50,744,966 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 20 50,957,171 - 50,986,231 (-) NCBI UU_Cfam_GSD_1.0
Slc44a2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
SLC44A2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 2 69,365,012 - 69,399,081 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 2 69,364,946 - 69,399,081 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 2 69,742,605 - 69,783,395 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SLC44A2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 6 9,607,224 - 9,646,535 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 6 9,630,113 - 9,646,389 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666074 10,326,343 - 10,349,797 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Slc44a2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 526 Count of miRNA genes: 243 Interacting mature miRNAs: 277 Transcripts: ENSRNOT00000049973 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
1558646 Swd5 Spike wave discharge measurement QTL 5 3.45 0.00036 brain electrophysiology trait (VT:0010557) brain spike-and-wave discharge frequency (CMO:0001742) 8 14906751 59906751 Rat 1357398 Slep3 Serum leptin concentration QTL 3 3.43 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 8 9712463 41866876 Rat 2317030 Wbc5 White blood cell count QTL 5 3.21 0.005 leukocyte quantity (VT:0000217) white blood cell count (CMO:0000027) 8 8736635 53736635 Rat 731182 Uae24 Urinary albumin excretion QTL 24 6.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 19331152 93965294 Rat 12880044 Am9 Aortic mass QTL 9 0.007 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 8 2097640 47097640 Rat 2317032 Ginf2 Gastrointestinal inflammation QTL 2 3.21 0.005 liver integrity trait (VT:0010547) liver granuloma severity score (CMO:0002157) 8 4705810 49705810 Rat 2301416 Bp315 Blood pressure QTL 315 0.008 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 7670578 52670578 Rat 631650 Stl6 Serum triglyceride level QTL 6 4 0.0019 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 10378157 112202585 Rat 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 3.8 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 8 8462195 110921472 Rat 631271 Lecl1 Lens clarity QTL 1 0.001 lens clarity trait (VT:0001304) age of onset/diagnosis of cataract (CMO:0001584) 8 18984168 84531599 Rat 2317036 Livw3 Liver weight QTL 3 2.43 0.01 liver mass (VT:0003402) liver weight to body weight ratio (CMO:0000633) 8 4705810 49705810 Rat 1598824 Memor4 Memory QTL 4 2.5 exploratory behavior trait (VT:0010471) total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443) 8 9712220 53356647 Rat 12880023 Bw184 Body weight QTL 184 0.001 body mass (VT:0001259) body weight (CMO:0000012) 8 2097640 47097640 Rat 9590084 Insglur5 Insulin/glucose ratio QTL 5 18.54 0.001 blood insulin amount (VT:0001560) calculated plasma insulin level (CMO:0002170) 8 1 24597739 Rat 1354595 Despr4 Despair related QTL 4 2.16 0.0036 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 8 7688955 52688955 Rat 1354627 Despr14 Despair related QTL 14 0.0056 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 8 7688955 52688955 Rat 12880028 Cm103 Cardiac mass QTL 103 0.02 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 8 2097640 47097640 Rat 2317051 Aia18 Adjuvant induced arthritis QTL 18 2.42 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 8 8736635 53736635 Rat 2317882 Alcrsp24 Alcohol response QTL 24 3.2 0.05 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 8 1 25902202 Rat 2317048 Ginf1 Gastrointestinal inflammation QTL 1 3.52 0.005 cecum mucosa thickness (VT:0010234) enterocolitis severity score (CMO:0002138) 8 4705810 49705810 Rat 2302367 Slep5 Serum leptin concentration QTL 5 3.43 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 8 9712463 41866876 Rat 12880025 Cm102 Cardiac mass QTL 102 0.044 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 8 2097640 47097640 Rat 61373 Mcs4 Mammary carcinoma susceptibility QTL 4 1.1 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 8 16290444 61290444 Rat
35.MMHAP10FD5.seq
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 19,902,641 - 19,902,812 (+) MAPPER mRatBN7.2 Rnor_6.0 8 22,383,166 - 22,383,336 NCBI Rnor6.0 Rnor_5.0 8 22,437,283 - 22,437,453 UniSTS Rnor5.0 RGSC_v3.4 8 20,448,877 - 20,449,047 UniSTS RGSC3.4 Celera 8 21,294,103 - 21,294,273 UniSTS Cytogenetic Map 8 q13 UniSTS
RH129061
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 8 28,181,164 - 28,181,405 (+) Marker Load Pipeline mRatBN7.2 8 19,905,013 - 19,905,254 (+) MAPPER mRatBN7.2 Rnor_6.0 8 22,385,538 - 22,385,778 NCBI Rnor6.0 Rnor_5.0 8 22,439,655 - 22,439,895 UniSTS Rnor5.0 RGSC_v3.4 8 20,451,249 - 20,451,489 UniSTS RGSC3.4 Celera 8 21,296,475 - 21,296,715 UniSTS Cytogenetic Map 8 q13 UniSTS
BF410447
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 19,894,416 - 19,894,522 (+) MAPPER mRatBN7.2 Rnor_6.0 8 22,374,939 - 22,375,044 NCBI Rnor6.0 Rnor_5.0 8 22,429,056 - 22,429,161 UniSTS Rnor5.0 RGSC_v3.4 8 20,440,449 - 20,440,554 UniSTS RGSC3.4 Celera 8 21,285,876 - 21,285,981 UniSTS RH 3.4 Map 8 180.8 UniSTS Cytogenetic Map 8 q13 UniSTS
RH135148
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 19,888,674 - 19,888,876 (+) MAPPER mRatBN7.2 Rnor_6.0 8 22,369,198 - 22,369,399 NCBI Rnor6.0 Rnor_5.0 8 22,423,315 - 22,423,516 UniSTS Rnor5.0 RGSC_v3.4 8 20,434,367 - 20,434,568 UniSTS RGSC3.4 Celera 8 21,280,135 - 21,280,336 UniSTS RH 3.4 Map 8 181.9 UniSTS Cytogenetic Map 8 q13 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000049973 ⟹ ENSRNOP00000051322
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 19,888,174 - 19,905,336 (+) Ensembl Rnor_6.0 Ensembl 8 22,368,745 - 22,385,864 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000109509 ⟹ ENSRNOP00000083031
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 19,870,888 - 19,905,342 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000115377 ⟹ ENSRNOP00000083534
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 19,870,915 - 19,905,336 (+) Ensembl
RefSeq Acc Id:
NM_001134715 ⟹ NP_001128187
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 28,164,372 - 28,181,496 (+) NCBI mRatBN7.2 8 19,888,222 - 19,905,345 (+) NCBI Rnor_6.0 8 22,368,745 - 22,385,869 (+) NCBI Rnor_5.0 8 22,405,625 - 22,439,986 (+) NCBI RGSC_v3.4 8 20,433,914 - 20,451,580 (+) RGD Celera 8 21,279,682 - 21,296,806 (+) RGD
Sequence:
GCTGCAGCGGGTGGCGGCTGTGTCCCGGAGAGCTCCGACAGCCCGGGCGCCGTCAGGGCTGCACCGCAGGAATGGGGAAGGATTCGCAGCATTACTACGGGAAGCACGGGACGCCTCAGAAATATGAC CCCACCTTTAAAGGACCCATTTACAACAGGGGATGCACGGATATCATTTGCTGTGTGTTGCTCTTCCTGGCCATCGTAGGCTACGTGGCTGTGGGCATCATAGCCTGGACCCATGGAGACCCTCGGAA GGTGATCTACCCCACTGATAGCCGGGGCGAGTTCTGTGGGCAAAAGGGAACAAAAAATGCGGACAAACCATTCTTGTTTTACTTCAACATCGTGAAGTGTGCCAGCCCCCTGGTCCTGCTGGAATTTC ACTGTCCCACCCCTCAGATCTGCGTGAAGCAGTGTCCAGACCGCTATCTCACCTTTCTGAGTGCGCGCAACTCTCGCGACTTTGACTACTACAAGCAGTTCTGTGTGCCCGGCTTCAAGAACAATAAA GGGGTAGCTGAGGTGCTCAGAGATGGGGAGTGCCCAGCGGTTATCATCCCCAGCAAACCCTTGGCCCAGCGGTGCTTCCCGGCCATCCATGCCAGCAAAGGGGTCCTCATGGTGGGCAATGAGACGAC CTATGAGGACGGACACGGCACCAGGAAGAATGTTACAGATCTAGTGGAGGGTGCCAAAAAGGCCAACAAGGTTCTAGAGGCCCGGCAGCTCGCCATGCAGATTTTTGAAGATTACACTGTATCCTGGT ACTGGATTGTCATAGGTCTGGTCATCGCCATGCTGCTGAGCCTCATGTTCATTGTCCTGCTGCGATTCCTGGCAGGCGTCATGGTCTGGGTGATGATCGTCATGGTGATTCTGGTACTTGGCTATGGC ATATTCCACTGCTACGCGGAGTACTCGAGACTCCGTGGAGAGGCAGGCTCCGACGTCTCCCTGGTGGACCTTGGCTTCCAGACGGACCTCCGAGTGTACCTGCACTTGAGGCAGACTTGGATGGCTTT CATGATCATTTTAAGCATCCTGGAAGTGGTCATCATCCTGTTACTCATCTTTCTGCGCAAAAGGATCTTGATCGCCATAGCCCTCATCAAAGAAGCCAGCAGGGCTGTGGGACATGTCATGTGCTCCA TGCTCTACCCACTGGTGACTTTCTTCCTCTTGTGTCTCTGCATTGCCTACTGGGCCAGCACTTCTGTCTTCCTGTCTACCTCTAATGTAGCCGTGTACAAGATTGTTGATGACACGCCCTGCCCACTT TTGGGGAAAACCTGCAACCCAGAGACCTTCCCATTGAATGAGAGCCGCCAGTGTCCTAATGGCCGCTGTCAGTTTGCCTTCTATGGCGGCGAGTCGACCTACCACCGTGCCCTGCTGGGCCTGCAGAT CTTCAATGCATTCATGTTCTTCTGGCTAGCCAACTTCGTGCTAGCCCTGGGCCAGGTGACACTGGCTGGAGCCTTTGCCTCCTATTACTGGGCTATGCGAAAGCCCGATGACATGCCTGCCTTCCCCC TCTTCTCTGCTTTTGGCCGCGCACTCAGGTACCACACGGGCTCCTTGGCTTTTGGCTCTCTTATCCTAGCCATCGTGCAGATCATCCGAGTGATGCTGGAGTACCTGGATCAGCGCCTGAAAGCTGCA CAGAACAAGTTTGCCAAGTTCCTCATGGTCTGTCTCAAGTGCTGCTTCTGGTGCCTAGAGAAGTTTATCAAATTCCTGAATAGGAATGCCTACATCATGATTGCTATCTATGGCACCAACTTCTGCAC CTCAGCCAGGAACGCCTTCTTCCTGCTTATGAGAAATATCATCAGGGTGGCCGTCCTGGACAAAGTTACAGACTTCCTCTTCCTGTTGGGCAAACTTCTGATTGTGGGTAGCGTGGGCATCCTGGCCT TCTTCTTCTTCACCCATCGGATCAGAATTGTGCAAGACACGGCCCCACCTCTCAATTATTATTGGGTCCCCATACTGACAGTGATCATTGGCTCCTACTTGATCGCGCACGGCTTCTTCAGCGTCTAT GGCATGTGCGTGGACACACTGTTCCTCTGTTTCTTGGAGGATCTGGAGAGAAACGACGGCTCAGCCGAGAGGCCTTACTTCATGTCTTCCACTCTCAAGAAACTCCTGAATAAAACCAACAAGAAAGT AGCAGAATCCTAAAGATGCCTGCCGCCCAGCCCTCTCAGGACGCTGTGATCCGGTGCTTGCTGTGCAGCTGGGTCCCAGTTCCCAGCTCATCAGACTTGTGTAACGTCACATCACTGCCTCTCTGCCA CCCTCCCCGAGTCCCCATTTCCAGGGACCCAGAGGAATTGGGGCATCTCTGTCCTATGCCAAAGGGCACTTGGGAGTTTTCGGTGCAGCCCTGGGAAATGGGACAGAATGGGTCTCTCCAATCCTTGC TGGCTCAGACGGTGCCAATATGGCGAAGCGACTTGAAGTTGAGGATGGGAGATGGCCCGAGGATGTGTGCAGCCAACTTCTTTGTATTTCGGTAACCCTTCTGGCCAAGAGGGGAAGACTGGATGAGA CGAGCTCAATGAACACTAGCTCCAAGCTTCCTAGCCAGAATAAAACTGGATCTCCACGACTGGCTGATGTCGCCTAAGGGCCAACAAATAACATGTCTCACTCTTAGTCCTTTGCAGCCTAGACAGAC GGTAAGAGGCCCACCTGCTTCTCTTCCACCAGGCTCCATAGCTGAGTGGAGTCACCAAGAGTGCCTTCACATGTAACCCCACCTCCAGCCTGGGGTGGCTGGGGTCACAGGAAGGAGTGTGTACCCAG AACTGGAGGAGTTTTCCAGATAAACATCCATCCGGGAGGAGGGCCCTGTGCAAGGAACGAGAGCGGTGGTGGGGGTTGGGAGTGGCTCTGGAAAACAGGCTTCTGTACTTAGATCCTACAGAGTACCT TTGACTGATGGCTTCCAAACGGAAAACTTGAGGTTGGAAAATGAGTGAAAATAGGGTCTGCCTCCCCACCCCTCTCTCTTCCAGTAATACACACTGCCCTCTTTGTGAGAGGAAAGAAACTGAAGTTC ACCCAAGGGATGGTTTCAGGGGATGAGGTGTGGGTGTGTTGTGTATTCCAAGTTAACTAGGCCTATCTGGTTTCTTTCACTTGAAACTAGAGACTCTGTTTGCCAAACTTCTTAATCTTGGGGGCCAG TAGACTGGTTCCTCACTTTACCTATCATATGCTAAGACCCTCCCCTCACCCCACTATGGCTATCCGTGAGATACCAGGATGTTGGAAACCAGAGGCTCCCAGCCTGGAGGCCCAGGCTTTCCTATGCC TGCCTGTGTGCCATCGCGCCCCACCCTTCTCTTGTATGCCCTGCCCTGTGCTTACGTAATTGCATTCCAGCCAGTTAATAAAGTGCCTCTTGTACAGATAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_006242651 ⟹ XP_006242713
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 28,147,023 - 28,181,496 (+) NCBI mRatBN7.2 8 19,870,868 - 19,905,345 (+) NCBI Rnor_6.0 8 22,351,278 - 22,385,869 (+) NCBI Rnor_5.0 8 22,405,625 - 22,439,986 (+) NCBI
Sequence:
GGGGCGGGGTCAGGCGGGGCAGGGCGGGGCCTGAGGCGCGGTGTCTCCCCGCCCGCTTGGGTTGGGGTCGCTCTGGCTTCGGACTCAGCTCCCCTCGGTTGCGGCCATGGAGGACGATCGGAAGGACG CAGTGTATGGGACGCCTCAGAAATATGACCCCACCTTTAAAGGACCCATTTACAACAGGGGATGCACGGATATCATTTGCTGTGTGTTGCTCTTCCTGGCCATCGTAGGCTACGTGGCTGTGGGCATC ATAGCCTGGACCCATGGAGACCCTCGGAAGGTGATCTACCCCACTGATAGCCGGGGCGAGTTCTGTGGGCAAAAGGGAACAAAAAATGCGGACAAACCATTCTTGTTTTACTTCAACATCGTGAAGTG TGCCAGCCCCCTGGTCCTGCTGGAATTTCACTGTCCCACCCCTCAGATCTGCGTGAAGCAGTGTCCAGACCGCTATCTCACCTTTCTGAGTGCGCGCAACTCTCGCGACTTTGACTACTACAAGCAGT TCTGTGTGCCCGGCTTCAAGAACAATAAAGGGGTAGCTGAGGTGCTCAGAGATGGGGAGTGCCCAGCGGTTATCATCCCCAGCAAACCCTTGGCCCAGCGGTGCTTCCCGGCCATCCATGCCAGCAAA GGGGTCCTCATGGTGGGCAATGAGACGACCTATGAGGACGGACACGGCACCAGGAAGAATGTTACAGATCTAGTGGAGGGTGCCAAAAAGGCCAACAAGGTTCTAGAGGCCCGGCAGCTCGCCATGCA GATTTTTGAAGATTACACTGTATCCTGGTACTGGATTGTCATAGGTCTGGTCATCGCCATGCTGCTGAGCCTCATGTTCATTGTCCTGCTGCGATTCCTGGCAGGCGTCATGGTCTGGGTGATGATCG TCATGGTGATTCTGGTACTTGGCTATGGCATATTCCACTGCTACGCGGAGTACTCGAGACTCCGTGGAGAGGCAGGCTCCGACGTCTCCCTGGTGGACCTTGGCTTCCAGACGGACCTCCGAGTGTAC CTGCACTTGAGGCAGACTTGGATGGCTTTCATGATCATTTTAAGCATCCTGGAAGTGGTCATCATCCTGTTACTCATCTTTCTGCGCAAAAGGATCTTGATCGCCATAGCCCTCATCAAAGAAGCCAG CAGGGCTGTGGGACATGTCATGTGCTCCATGCTCTACCCACTGGTGACTTTCTTCCTCTTGTGTCTCTGCATTGCCTACTGGGCCAGCACTTCTGTCTTCCTGTCTACCTCTAATGTAGCCGTGTACA AGATTGTTGATGACACGCCCTGCCCACTTTTGGGGAAAACCTGCAACCCAGAGACCTTCCCATTGAATGAGAGCCGCCAGTGTCCTAATGGCCGCTGTCAGTTTGCCTTCTATGGCGGCGAGTCGACC TACCACCGTGCCCTGCTGGGCCTGCAGATCTTCAATGCATTCATGTTCTTCTGGCTAGCCAACTTCGTGCTAGCCCTGGGCCAGGTGACACTGGCTGGAGCCTTTGCCTCCTATTACTGGGCTATGCG AAAGCCCGATGACATGCCTGCCTTCCCCCTCTTCTCTGCTTTTGGCCGCGCACTCAGGTACCACACGGGCTCCTTGGCTTTTGGCTCTCTTATCCTAGCCATCGTGCAGATCATCCGAGTGATGCTGG AGTACCTGGATCAGCGCCTGAAAGCTGCACAGAACAAGTTTGCCAAGTTCCTCATGGTCTGTCTCAAGTGCTGCTTCTGGTGCCTAGAGAAGTTTATCAAATTCCTGAATAGGAATGCCTACATCATG ATTGCTATCTATGGCACCAACTTCTGCACCTCAGCCAGGAACGCCTTCTTCCTGCTTATGAGAAATATCATCAGGGTGGCCGTCCTGGACAAAGTTACAGACTTCCTCTTCCTGTTGGGCAAACTTCT GATTGTGGGTAGCGTGGGCATCCTGGCCTTCTTCTTCTTCACCCATCGGATCAGAATTGTGCAAGACACGGCCCCACCTCTCAATTATTATTGGGTCCCCATACTGACAGTGATCATTGGCTCCTACT TGATCGCGCACGGCTTCTTCAGCGTCTATGGCATGTGCGTGGACACACTGTTCCTCTGTTTCTTGGAGGATCTGGAGAGAAACGACGGCTCAGCCGAGAGGCCTTACTTCATGTCTTCCACTCTCAAG AAACTCCTGAATAAAACCAACAAGAAAGTAGCAGAATCCTAAAGATGCCTGCCGCCCAGCCCTCTCAGGACGCTGTGATCCGGTGCTTGCTGTGCAGCTGGGTCCCAGTTCCCAGCTCATCAGACTTG TGTAACGTCACATCACTGCCTCTCTGCCACCCTCCCCGAGTCCCCATTTCCAGGGACCCAGAGGAATTGGGGCATCTCTGTCCTATGCCAAAGGGCACTTGGGAGTTTTCGGTGCAGCCCTGGGAAAT GGGACAGAATGGGTCTCTCCAATCCTTGCTGGCTCAGACGGTGCCAATATGGCGAAGCGACTTGAAGTTGAGGATGGGAGATGGCCCGAGGATGTGTGCAGCCAACTTCTTTGTATTTCGGTAACCCT TCTGGCCAAGAGGGGAAGACTGGATGAGACGAGCTCAATGAACACTAGCTCCAAGCTTCCTAGCCAGAATAAAACTGGATCTCCACGACTGGCTGATGTCGCCTAAGGGCCAACAAATAACATGTCTC ACTCTTAGTCCTTTGCAGCCTAGACAGACGGTAAGAGGCCCACCTGCTTCTCTTCCACCAGGCTCCATAGCTGAGTGGAGTCACCAAGAGTGCCTTCACATGTAACCCCACCTCCAGCCTGGGGTGGC TGGGGTCACAGGAAGGAGTGTGTACCCAGAACTGGAGGAGTTTTCCAGATAAACATCCATCCGGGAGGAGGGCCCTGTGCAAGGAACGAGAGCGGTGGTGGGGGTTGGGAGTGGCTCTGGAAAACAGG CTTCTGTACTTAGATCCTACAGAGTACCTTTGACTGATGGCTTCCAAACGGAAAACTTGAGGTTGGAAAATGAGTGAAAATAGGGTCTGCCTCCCCACCCCTCTCTCTTCCAGTAATACACACTGCCC TCTTTGTGAGAGGAAAGAAACTGAAGTTCACCCAAGGGATGGTTTCAGGGGATGAGGTGTGGGTGTGTTGTGTATTCCAAGTTAACTAGGCCTATCTGGTTTCTTTCACTTGAAACTAGAGACTCTGT TTGCCAAACTTCTTAATCTTGGGGGCCAGTAGACTGGTTCCTCACTTTACCTATCATATGCTAAGACCCTCCCCTCACCCCACTATGGCTATCCGTGAGATACCAGGATGTTGGAAACCAGAGGCTCC CAGCCTGGAGGCCCAGGCTTTCCTATGCCTGCCTGTGTGCCATCGCGCCCCACCCTTCTCTTGTATGCCCTGCCCTGTGCTTACGTAATTGCATTCCAGCCAGTTAATAAAGTGCCTCTTGTACAGAT A
hide sequence
RefSeq Acc Id:
XM_039081711 ⟹ XP_038937639
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 28,164,180 - 28,180,331 (+) NCBI mRatBN7.2 8 19,888,033 - 19,904,081 (+) NCBI
RefSeq Acc Id:
XM_063265728 ⟹ XP_063121798
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 28,164,180 - 28,181,496 (+) NCBI
RefSeq Acc Id:
XM_063265729 ⟹ XP_063121799
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 28,147,023 - 28,181,496 (+) NCBI
RefSeq Acc Id:
NP_001128187 ⟸ NM_001134715
- UniProtKB:
B4F795 (UniProtKB/Swiss-Prot)
- Sequence:
MGKDSQHYYGKHGTPQKYDPTFKGPIYNRGCTDIICCVLLFLAIVGYVAVGIIAWTHGDPRKVIYPTDSRGEFCGQKGTKNADKPFLFYFNIVKCASPLVLLEFHCPTPQICVKQCPDRYLTFLSARN SRDFDYYKQFCVPGFKNNKGVAEVLRDGECPAVIIPSKPLAQRCFPAIHASKGVLMVGNETTYEDGHGTRKNVTDLVEGAKKANKVLEARQLAMQIFEDYTVSWYWIVIGLVIAMLLSLMFIVLLRFL AGVMVWVMIVMVILVLGYGIFHCYAEYSRLRGEAGSDVSLVDLGFQTDLRVYLHLRQTWMAFMIILSILEVVIILLLIFLRKRILIAIALIKEASRAVGHVMCSMLYPLVTFFLLCLCIAYWASTSVF LSTSNVAVYKIVDDTPCPLLGKTCNPETFPLNESRQCPNGRCQFAFYGGESTYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWAMRKPDDMPAFPLFSAFGRALRYHTGSLAFGSLILA IVQIIRVMLEYLDQRLKAAQNKFAKFLMVCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFCTSARNAFFLLMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVP ILTVIIGSYLIAHGFFSVYGMCVDTLFLCFLEDLERNDGSAERPYFMSSTLKKLLNKTNKKVAES
hide sequence
RefSeq Acc Id:
XP_006242713 ⟸ XM_006242651
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I5ZYC2 (UniProtKB/TrEMBL), A6JNR3 (UniProtKB/TrEMBL)
- Sequence:
MEDDRKDAVYGTPQKYDPTFKGPIYNRGCTDIICCVLLFLAIVGYVAVGIIAWTHGDPRKVIYPTDSRGEFCGQKGTKNADKPFLFYFNIVKCASPLVLLEFHCPTPQICVKQCPDRYLTFLSARNSR DFDYYKQFCVPGFKNNKGVAEVLRDGECPAVIIPSKPLAQRCFPAIHASKGVLMVGNETTYEDGHGTRKNVTDLVEGAKKANKVLEARQLAMQIFEDYTVSWYWIVIGLVIAMLLSLMFIVLLRFLAG VMVWVMIVMVILVLGYGIFHCYAEYSRLRGEAGSDVSLVDLGFQTDLRVYLHLRQTWMAFMIILSILEVVIILLLIFLRKRILIAIALIKEASRAVGHVMCSMLYPLVTFFLLCLCIAYWASTSVFLS TSNVAVYKIVDDTPCPLLGKTCNPETFPLNESRQCPNGRCQFAFYGGESTYHRALLGLQIFNAFMFFWLANFVLALGQVTLAGAFASYYWAMRKPDDMPAFPLFSAFGRALRYHTGSLAFGSLILAIV QIIRVMLEYLDQRLKAAQNKFAKFLMVCLKCCFWCLEKFIKFLNRNAYIMIAIYGTNFCTSARNAFFLLMRNIIRVAVLDKVTDFLFLLGKLLIVGSVGILAFFFFTHRIRIVQDTAPPLNYYWVPIL TVIIGSYLIAHGFFSVYGMCVDTLFLCFLEDLERNDGSAERPYFMSSTLKKLLNKTNKKVAES
hide sequence
Ensembl Acc Id:
ENSRNOP00000051322 ⟸ ENSRNOT00000049973
RefSeq Acc Id:
XP_038937639 ⟸ XM_039081711
- Peptide Label:
isoform X1
- UniProtKB:
A0A8L2QQY0 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000083534 ⟸ ENSRNOT00000115377
Ensembl Acc Id:
ENSRNOP00000083031 ⟸ ENSRNOT00000109509
RefSeq Acc Id:
XP_063121799 ⟸ XM_063265729
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6G961 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063121798 ⟸ XM_063265728
- Peptide Label:
isoform X1
- UniProtKB:
A0A8L2QQY0 (UniProtKB/TrEMBL)
RGD ID: 13695779
Promoter ID: EPDNEW_R6303
Type: single initiation site
Name: Slc44a2_1
Description: solute carrier family 44 member 2
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 8 22,368,734 - 22,368,794 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-02-24
Slc44a2
solute carrier family 44 member 2
Slc44a2
solute carrier family 44 (choline transporter), member 2
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2013-08-02
Slc44a2
solute carrier family 44 (choline transporter), member 2
Slc44a2
solute carrier family 44, member 2
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Slc44a2
solute carrier family 44, member 2
Slc44a2_predicted
solute carrier family 44, member 2 (predicted)
'predicted' is removed
2292626
APPROVED
2006-03-30
Slc44a2_predicted
solute carrier family 44, member 2 (predicted)
RGD1309680_predicted
similar to RIKEN cDNA 1110028E10 (predicted)
Symbol and Name updated
1299863
APPROVED
2005-01-20
RGD1309680_predicted
similar to RIKEN cDNA 1110028E10 (predicted)
LOC363024_predicted
Symbol and Name status set to approved
1331353
APPROVED
2005-01-12
LOC363024_predicted
similar to RIKEN cDNA 1110028E10 (predicted)
Symbol and Name status set to provisional
70820
PROVISIONAL